Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:OCDX

Ortho Clinical Diagnostics (OCDX) Stock Price, News & Analysis

Ortho Clinical Diagnostics logo

About Ortho Clinical Diagnostics Stock (NASDAQ:OCDX)

Advanced Chart

Key Stats

Today's Range
$17.63
$17.63
50-Day Range
$17.63
$17.63
52-Week Range
$16.04
$22.99
Volume
5,400 shs
Average Volume
1.24 million shs
Market Capitalization
$3.92 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive OCDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ortho Clinical Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

OCDX Stock News Headlines

Novacyt: Innovative Clinical Diagnostics
ThinkorSwim founder's 389% winner (exclusive access)
389% in 48 hours. SPX 500%. VIX 67%. These are real trades — not backtests — made live in front of thousands. Now the team behind those results is offering a bold experiment: full access to their live trading room, and you name the price. No $2,000 paywall. No pressure. Just proven traders, real-time decisions… and one free trade to get started.
See More Headlines

OCDX Stock Analysis - Frequently Asked Questions

Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) released its quarterly earnings results on Wednesday, November, 3rd. The company reported $0.21 earnings per share for the quarter, beating the consensus estimate of $0.14 by $0.07. The company earned $522.50 million during the quarter, compared to analysts' expectations of $485.36 million. Ortho Clinical Diagnostics had a negative net margin of 0.02% and a positive trailing twelve-month return on equity of 41.71%.
Read the conference call transcript
.

Ortho Clinical Diagnostics (OCDX) raised $1.5 billion in an initial public offering on Thursday, January 28th 2021. The company issued 70,000,000 shares at $20.00-$23.00 per share. J.P. Morgan, BofA Securities, Goldman Sachs, Barclays and Morgan Stanley acted as the underwriters for the IPO and Citigroup, Credit Suisse, UBS Investment Bank, Evercore ISI, Piper Sandler, ING, Macquarie Capital, Nomura, TCG Capital Markets, Drexel Hamilton, H.C. Wainwright & Co., Ramirez & Co. and Siebert Williams Shank were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ortho Clinical Diagnostics investors own include Meta Platforms (META), WPP (WPP), Garmin (GRMN), Li Auto (LI), Advanced Micro Devices (AMD), Kinsale Capital Group (KNSL) and

Company Calendar

Last Earnings
11/03/2021
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Diagnostic Substances
Sub-Industry
N/A
Current Symbol
NASDAQ:OCDX
CIK
1828443
Fax
N/A
Employees
4,800
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
21.77
P/E Growth
1.66
Net Income
-$54.30 million
Net Margins
-0.02%
Pretax Margin
1.38%
Return on Equity
41.71%
Return on Assets
5.10%

Debt

Debt-to-Equity Ratio
4.91
Current Ratio
1.89
Quick Ratio
1.29

Sales & Book Value

Annual Sales
$2.04 billion
Price / Sales
1.92
Cash Flow
$2.28 per share
Price / Cash Flow
7.73
Book Value
$1.99 per share
Price / Book
8.86

Miscellaneous

Outstanding Shares
222,585,000
Free Float
N/A
Market Cap
$3.92 billion
Optionable
Not Optionable
Beta
1.32
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:OCDX) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners